Group 1 - Madison Mid Cap Fund's Class Y returned 5.2% in Q2 2025, underperforming the Russell Midcap Index which increased by 8.5% [1] - The fund highlighted Dollar Tree, Inc. (NASDAQ:DLTR) as a significant stock, which saw a one-month return of -14.79% but a 52-week gain of 32.75% [2] - Dollar Tree's market capitalization was reported at $19.43 billion as of September 19, 2025, with shares closing at $95.26 [2] Group 2 - The fund sold its holdings in Dollar Tree, citing increased risk due to tariff announcements and a deteriorating risk profile, despite positive performance indicators from the company [3] - Dollar Tree's net sales for Q2 2025 increased by 12.3% to $4.6 billion, driven by comparable sales growth [4] - The number of hedge funds holding Dollar Tree decreased from 67 to 59 in the second quarter of 2025, indicating a decline in popularity among institutional investors [4]

Group 1 - Quipt Home Medical Corp. (NASDAQ:QIPT) is identified as a fundamentally strong penny stock with recent investment interest from Nuveen LLC, which acquired 150,046 shares valued at approximately $350,000, representing nearly 0.35% ownership of the company [1] - The company is enhancing its growth through strategic partnerships, recently completing a venture transaction with three health systems and two hospitals [2] - Quipt's acquisition of Hart Medical Equipment for $17.4 million results in a 60% ownership interest, with the remaining shares held by several health systems, contributing to stabilized revenue and adjusted EBITDA while creating additional growth opportunities [3] Group 2 - Quipt Home Medical Corp. is based in Kentucky and specializes in providing durable and home medical equipment, focusing on high-quality home care solutions such as nebulizers and invasive ventilation [4]

Core Insights - Hormel Foods Corporation (NYSE:HRL) is recognized as one of the 13 incredibly cheap dividend stocks to invest in [1] - The company has transitioned from a primarily meat-focused business to a broader global branded food enterprise, generating over $12 billion in annual revenue from more than 40 brands worldwide [3] - Hormel Foods is classified as a Dividend King, having increased its dividend payouts for 59 consecutive years, currently offering a quarterly dividend of $0.29 per share with a dividend yield of 4.67% as of September 19 [3] Company Overview - Hormel Foods Corporation is an American multinational food processing company operating through three main segments: retail, foodservice, and international [2] - The retail segment includes well-known brands such as Planters, SPAM, Skippy, Herdez, Jennie-O, and Hormel [2] - The foodservice division supplies products like pizza toppings and bacon to restaurants and other food outlets, while the international business encompasses global sales and investments abroad [2] Financial Performance - The company has evolved significantly, now generating more than $12 billion in annual revenue [3] - Hormel Foods has a strong track record of dividend growth, being a Dividend King with 59 years of consecutive dividend increases [3] - The current quarterly dividend is $0.29 per share, reflecting a dividend yield of 4.67% [3]

Core Insights - AptarGroup, Inc. is recognized as one of the most oversold healthcare stocks in 2025 [1] - The company showcased its growth strategy and positive long-term outlook during its Investor Day on September 9, 2025, highlighting strong momentum in the Pharma segment [2] Financial Performance - In Q2 2025, AptarGroup reported a 6% increase in revenue year-over-year, with net income rising 24% to $112 million and adjusted EBITDA increasing by 13% [3] - Earnings per share grew by 25%, driven by operational efficiencies and strong demand in the Pharma and Closures segments [3] Shareholder Returns - The company announced a nearly 7% increase in its quarterly dividend to $0.48 per share, marking 32 consecutive years of dividend growth [4] - AptarGroup returned $100 million to shareholders through dividends and share repurchases in Q2, totaling $210 million for the first half of the year, reflecting a shareholder-friendly capital allocation strategy [4]

Group 1: Market Overview - US equities experienced a significant rally in Q2 2025, with the S&P 500 returning 10.9% and the Russell Midcap Growth Index advancing 18.2% [1] - Growth stocks outperformed value counterparts across market caps, contributing to the strategy's outperformance of the benchmark [1] Group 2: ClearBridge Growth Strategy Performance - The strategy's outperformance was driven by strong performance in the "mid cap plus" segment and solid stock selection in IT, industrials, and financials [1] Group 3: Axon Enterprise, Inc. Overview - Axon Enterprise, Inc. (NASDAQ:AXON) reported a one-month return of -1.34% but gained 95.99% over the last 52 weeks, closing at $750.67 per share with a market capitalization of $58.93 billion on September 16, 2025 [2] - The company generated $669 million in revenue in Q2 2025, marking a 33% year-over-year increase and its 14th consecutive quarter of revenue growth exceeding 25% [4] Group 4: Strategic Positioning - Axon Enterprise, Inc. complements existing defense holdings like L3Harris Technologies, providing exposure to aerospace and public safety markets, with significant growth and margin expansion potential [3]

Group 1 - RTX Corporation (NYSE:RTX) is highlighted as one of Jim Cramer's stock picks, benefiting from political narratives and defense spending [1][3] - The company secured significant defense contracts, including a $760 million contract from the U.S. Air Force and a $205 million contract for the Phalanx Close-In Weapon System [2] - RTX Corporation has strong institutional backing, with 71 hedge funds holding stakes as of Q2 2025, indicating robust investor interest [3] Group 2 - RTX Corporation is a multinational aerospace and defense company formed in 2020 through the merger of Raytheon Company and United Technologies Corporation's aerospace businesses [4] - The company develops and manufactures advanced systems, including aircraft engines, avionics, missiles, and defense systems [4]

Group 1 - Cava Group Inc. is recognized as a promising stock with significant upside potential, despite a recent price target reduction from Argus to $76 from $110 while maintaining a Buy rating [1][3] - For Q2 2025, Cava Group reported revenue of $278.2 million, marking a 20.3% year-over-year increase, with adjusted EBITDA of $42.1 million, a 22.6% increase from Q2 2024, and a net income of $18.4 million [2] - The company opened 16 new restaurants in the quarter, increasing the total number of locations to 398, and reported a restaurant-level profit margin of 26.3% [2][4] Group 2 - Cava Group has lowered its same-store sales growth estimates for the year, which is viewed as a realistic adjustment [1][3] - The company anticipates that tariffs on certain products may impact costs, but brand health scores, including NPS and value scores, have shown improvement [3] - Cava is leveraging technology such as Hyphen and AI-camera-vision to enhance operational efficiency and digital order accuracy [3]

Group 1 - Capital One Financial Corporation (NYSE:COF) is considered one of the best cheap stocks for beginners, with a Buy rating maintained by KBW and a price target of $260.00 [1] - In fiscal Q2 2025, Capital One reported a net loss of $4.3 billion, a significant decline from a net income of $1.4 billion in Q1 2025, with an adjusted net income of $5.48 per diluted common share [2] - The company's operations are segmented into Credit Card, Consumer Banking, and Commercial Banking [3]

Group 1 - SSR Mining Inc. produced 120,191 gold equivalent ounces at an all-in sustaining cost (AISC) of $2,068 per ounce, resulting in a record net income of $90.1 million for Q2 2025, equating to $0.42 per share [1] - The company reported an adjusted net income of $110.1 million, or $0.51 per share, with liquidity standing at $912.1 million, including $412.1 million in cash [1] - Operating cash flow was $157.8 million, with free cash flow amounting to $98.4 million, driven by a notable contribution of 44,062 ounces of gold from CC&V at an AISC of $1,339 per ounce [1] Group 2 - SSR Mining maintained its 2025 gold equivalent ounce projection of 410,000-480,000, while reclamation expenses increased by $12.9 million, raising total remediation estimates to between $262.9 million and $312.9 million [2] - Anticipated silver output at Puna for 2026 is projected to be 7-8 million ounces, exceeding previous forecasts and extending the mine's life [2] - The Hod Maden project progressed with an expenditure of $16.2 million in Q2, positioning SSR Mining for long-term portfolio expansion [2]

Company Overview - BrightSpring Health Services Inc. (NASDAQ:BTSG) operates as a home and community-based healthcare services platform in the US, divided into two segments: Pharmacy Solutions and Provider Services [4]. Financial Performance - In Q2 2025, BrightSpring Health reported total revenue of $3.1 billion, reflecting a 29% year-over-year growth, primarily driven by the Pharmacy Solutions segment [2][3]. - The Pharmacy Solutions segment experienced a 32% increase in revenue, reaching $2.8 billion, with infusion and specialty revenue surging by 39% to $2.2 billion and specialty scripts growing by 38% [2][3]. - The Provider Services segment contributed to growth with an 11% revenue increase to $358 million, supported by home healthcare revenue rising 17% to $185 million, rehab revenue increasing by 9% to $73 million, and personal care revenue growing by 4% to $100 million [3]. - Overall gross profit for the company increased by 20% year-over-year to $375 million [3]. Analyst Ratings - Deutsche Bank analyst Pito Chickering raised the price target for BrightSpring Health to $30 from $25 while maintaining a Buy rating on the shares [1][3].